Evaluation of Novel N1-Methyl-2-phenylindol-3-ylglyoxylamides as a New Chemotype of 18 kDa Translocator Protein-Selective Ligand Suitable for the Development of Positron Emission Tomography Radioligands
- 6 December 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 54 (1) , 366-373
Abstract
A novel series of N1-methyl-(2-phenylindol-3-yl)glyoxylamides, 19−31, designed in accordance with our previously reported pharmacophore/topological model, showed high affinity for the 18 kDa translocator protein (TSPO) and paved the way for developing a new radiolabeled probe. Thus ligand 31, N,N-di-n-propyl-(N1-methyl-2-(4′-nitrophenyl)indol-3-yl)glyoxylamide, featuring the best combination of affinity and lipophilicity, was labeled with carbon-11 for evaluation with positron emission tomography (PET) in monkey. After intravenous injection, [11C]31 entered brain to give a high proportion of TSPO-specific binding. These findings augur well for the future application of [11C]31 in humans. Consequently, the binding of 31 to human TSPO was tested on samples of brain membranes from deceased subjects who through ethically approved in vitro study had previously been established to be high-affinity binders (HABs), mixed-affinity binders (MABs), or low-affinity binders (LABs) for the known TSPO ligand, PBR28 (2). 31 showed high affinity for HABs, MABs, and LABs. In conclusion, [11C]31 represents a promising new chemotype for developing novel TSPO radioligands as biomarkers of neuroinflammation.Keywords
This publication has 40 references indexed in Scilit:
- Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of NeuroinflammationJournal of Cerebral Blood Flow & Metabolism, 2010
- Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarkerNeuroImage, 2010
- PET radiotracers: crossing the blood–brain barrier and surviving metabolismTrends in Pharmacological Sciences, 2009
- Cholesterol transport in steroid biosynthesis: Role of protein–protein interactions and implications in disease statesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Single-Step High-Yield Radiosynthesis and Evaluation of a Sensitive18F-Labeled Ligand for Imaging Brain Peripheral Benzodiazepine Receptors with PETJournal of Medicinal Chemistry, 2009
- Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repairPharmacology & Therapeutics, 2008
- Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammationNeuroImage, 2008
- Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptorsNeuroImage, 2008
- The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imagingProgress in Neurobiology, 2006
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973